Aug 17, 2023 / 08:30AM GMT
Operator
Ladies and gentlemen, thank you for standing by. Welcome and thank you for joining the Coloplast 9 months 2022/'23 Earnings Release Conference Call. (Operator Instructions)
And I would now like to turn the conference over to Kristian Villumsen, President and CEO. Please go ahead.
Kristian Villumsen - Coloplast A/S-President&CEO
Thank you very much, operator and good morning. And welcome to our 9 Months '22/'23 Conference Call. I'm Kristian Villumsen, the CEO of Coloplast and I'm joined by our CFO, Anders Lonning-Skovgaard; and our Investor Relations team. We'll start with a short presentation by Anders and myself and then open up for questions.
Please turn to Slide #3. We delivered 8% organic growth and our reported EBIT margin before special items of 28% in the third quarter. Return on invested capital after tax and before special items was 19% reflecting impact from the Atos Medical acquisition. We continue to broadly outgrow the market and more importantly, we continue to help a lot
Q3 2023 Coloplast A/S Earnings Call Transcript
Feb 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers